| Berkshire Physical Therapy & Wellness | |
|
740 Williams St, Pittsfield, MA 01201-7463 | |
| (413) 447-8070 | |
| Not Available |
| Full Name | Berkshire Physical Therapy & Wellness |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 740 Williams St, Pittsfield, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174729313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 16522 (Massachusetts) | Primary |
| Provider Name | Robert A Paduano |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275543753 PECOS PAC ID: 7416966650 Enrollment ID: I20060417000126 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Thomas M Cooney |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1821056342 PECOS PAC ID: 2365346756 Enrollment ID: I20071004000439 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Brent B Sylvia |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1891900213 PECOS PAC ID: 7810084522 Enrollment ID: I20071027000036 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Rachel E Welch |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1215980586 PECOS PAC ID: 4082645957 Enrollment ID: I20090626000005 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Tiffany R Brower |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1508927203 PECOS PAC ID: 6305028861 Enrollment ID: I20110304000824 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Nicole Tucker |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1134425291 PECOS PAC ID: 4688857451 Enrollment ID: I20110331000920 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Amanda Roberts |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1740658079 PECOS PAC ID: 5799087938 Enrollment ID: I20160105002980 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Williston Mortenson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1023562881 PECOS PAC ID: 2668753898 Enrollment ID: I20170103000108 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Joy M Milani |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1659555340 PECOS PAC ID: 9133425242 Enrollment ID: I20200210000650 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Shaunna M Houle |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1508910878 PECOS PAC ID: 4284636283 Enrollment ID: I20200304002592 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | John Delahanty |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1508532144 PECOS PAC ID: 6204231236 Enrollment ID: I20210830000298 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Jaclyn Farrell |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1578226379 PECOS PAC ID: 6800281031 Enrollment ID: I20220324001581 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Provider Name | Elizabeth Kastrinakis |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1831808351 PECOS PAC ID: 5799155057 Enrollment ID: I20221230001633 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Berkshire Physical Therapy & Wellness 740 Williams St, Pittsfield, MA 01201-7463 Ph: (413) 447-8070 | Berkshire Physical Therapy & Wellness 740 Williams St, Pittsfield, MA 01201-7463 Ph: (413) 447-8070 |
News Archive
Neuroscientist and executive advisor Dr Tara Swart announced the results of her study into the mental resilience of journalists last night at a London Press Club event held at the Corinthia Hotel.
EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.
Men and women with major depressive disorder have opposite changes in the expression of the same genes, according to a new postmortem brain study by researchers at the University of Pittsburgh and Centre for Addiction and Mental Health, Toronto, Canada.
Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.
› Verified 9 days ago
Mr. Brian Joseph Duquette, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 24 Park Street, Pittsfield, MA 01201 Phone: 413-629-1919 Fax: 413-629-1918 | |
Ms. Susan M Sparks, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 740 Williams St, Pittsfield, MA 01201 Phone: 413-447-8070 Fax: 413-445-4918 | |
Dr. Elise Nichols, D.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 24 Park St, Pittsfield, MA 01201 Phone: 413-629-1919 | |
Jan Greene Physical Therapy Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 212 South Street, Pittsfield, MA 01201 Phone: 413-445-8030 Fax: 413-445-8033 | |
Williston Mortenson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 740 Williams St, Ste 1, Pittsfield, MA 01201 Phone: 413-447-8070 Fax: 413-445-4918 | |
Sarah Acheson, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 255 Lebanon Ave, Pittsfield, MA 01201 Phone: 413-499-2334 Fax: 413-443-1565 | |
Dr. Geoffrey L Abraskin, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 North St, Suite 300, Pittsfield, MA 01201 Phone: 413-236-8500 Fax: 413-236-8501 |